Whitehawk
8 known investors
Find your way into Whitehawk
120 people in our graph share verified history with the Whitehawk team — schools, employers, funds. One of them is your warm intro.
Tom Danilekunlockedknows Dave Lennon · together at Columbia University (overlapped)
×4knows the team · via Joan & Sanford I. Weill Medical College of Cornell University
×7knows the team · via Columbia University
Whitehawk Therapeutics develops antibody-drug conjugate (ADC) therapeutics through intentional clinical development. The company brings expertise in biotech R&D and commercialization to treat patients using its ADC platform.
Founders & leadership
DL
Dave Lennon, PhDPresident & CEO
DL
Dave LennoninPresident & CEOPresident and CEO of Whitehawk Therapeutics, which develops antibody-drug conjugate therapeutics for treating patients.
Investors · 8
Also in the syndicate · 6
Acuta Capital PartnersADAR1 Capital ManagementCoastlands CapitalKVP CapitalQVTStemPoint Capital LP
Funding
SEC filings, press & company announcements- Undisclosed amountprivate placementMay 2026
Acuta Capital Partners, ADAR1 Capital Management, Avoro Capital, Coastlands Capital, Invus, KVP Capital, QVT, StemPoint Capital LP
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Whitehawk do?
- Whitehawk Therapeutics develops antibody-drug conjugate (ADC) therapeutics through intentional clinical development. The company brings expertise in biotech R&D and commercialization to treat patients using its ADC platform.
- Who are Whitehawk's investors?
- Whitehawk's investors include Avoro Capital Advisors, Invus.